MetLife Stock Based Compensation To Revenue from 2010 to 2024

MET Stock  USD 88.25  0.49  0.56%   
MetLife Stock Based Compensation To Revenue yearly trend continues to be comparatively stable with very little volatility. Stock Based Compensation To Revenue will likely drop to 0 in 2024. Stock Based Compensation To Revenue is a metric that compares the total value of stock-based compensation granted by MetLife to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards. View All Fundamentals
 
Stock Based Compensation To Revenue  
First Reported
2010-12-31
Previous Quarter
0.003027
Current Value
0.002466
Quarterly Volatility
0.00039966
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check MetLife financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MetLife's main balance sheet or income statement drivers, such as Depreciation And Amortization of 478 M, Interest Expense of 795.6 M or Selling General Administrative of 5.8 B, as well as many indicators such as Price To Sales Ratio of 0.72, Dividend Yield of 0.0225 or PTB Ratio of 1.76. MetLife financial statements analysis is a perfect complement when working with MetLife Valuation or Volatility modules.
  
Check out the analysis of MetLife Correlation against competitors.
For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.

Latest MetLife's Stock Based Compensation To Revenue Growth Pattern

Below is the plot of the Stock Based Compensation To Revenue of MetLife over the last few years. It is a metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards. MetLife's Stock Based Compensation To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MetLife's overall financial position and show how it may be relating to other accounts over time.
Stock Based Compensation To Revenue10 Years Trend
Very volatile
   Stock Based Compensation To Revenue   
       Timeline  

MetLife Stock Based Compensation To Revenue Regression Statistics

Arithmetic Mean0
Geometric Mean0
Coefficient Of Variation17.10
Mean Deviation0.0003
Median0
Standard Deviation0.0004
Sample Variance0.00000016
Range0.0018
R-Value0.02
Mean Square Error0.00000017
R-Squared0.0005
Significance0.94
Slope0.00000204
Total Sum of Squares0.00000224

MetLife Stock Based Compensation To Revenue History

2024 0.002466
2023 0.003027
2022 0.002632
2021 0.002434
2020 0.001872
2019 0.002155
2018 0.001266

About MetLife Financial Statements

MetLife shareholders use historical fundamental indicators, such as Stock Based Compensation To Revenue, to determine how well the company is positioned to perform in the future. Although MetLife investors may analyze each financial statement separately, they are all interrelated. The changes in MetLife's assets and liabilities, for example, are also reflected in the revenues and expenses on on MetLife's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for MetLife Stock Analysis

When running MetLife's price analysis, check to measure MetLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetLife is operating at the current time. Most of MetLife's value examination focuses on studying past and present price action to predict the probability of MetLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetLife's price. Additionally, you may evaluate how the addition of MetLife to your portfolios can decrease your overall portfolio volatility.